Аннотация Проведено сравнительное изучение влияния профилактического введения
двух бета-блокаторов с различным механизмом действия на морфо-функциональные …

Objective: This review covers the pharmacokinetics and pharmacodynamic of β-blockers,
the rationale for their use, some recent controversies in its use for managing hypertension …

Abstract Introduction: Hypertension,“The silent killer” is a multifactorial disorder which is
asymptomatic and if left untreated leads to lethal complications. Nebivolol is a third …

Hypertension is often associated with increased oxidative stress and systemic insulin
resistance. Use of β-adrenergic receptor blockers in hypertension is limited because of …

Introduction Only 50% of hypertensive patients receive an appropriate treatment to
normalize blood pressure (BP). Although monotherapy is often adequate in normalizing BP …

Atenolol and metoprolol succinate, dosed once daily, have different pharmacokinetic
profiles. This study tests the hypothesis that differences that are especially noted in the early …

Применение ß-адреноблокаторов в медицине насчитывает уже более 50 лет. Впервые
С. Powell и J. Slater применили ß-адреноблокаторы для блокады ß-адренорецепторов …

Introduction: Hypertension and diabetes are two of the most important modifiable risk factors
for cardiovascular and renal disease. The majority of patients with diabetes also have high …

Insulin resistance and/or compensatory hyperinsulinemia are associated with hypertension,
obesity, dyslipidemia, and glucose intolerance. Insulin resistance and hyperinsulinemia are …

Reduction of blood pressure to guideline goals (ie,< 130/80 mm Hg) in persons with
diabetes is crucial to optimally reduce cardiovascular events and kidney disease …